相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vaccination among Medicare-fee-for service beneficiaries: Characteristics and predictors of vaccine receipt, 2014-2017
Angela K. Shen et al.
VACCINE (2019)
Costs of herpes zoster complications in older adults: A cohort study of US claims database
Juliana L. Meyers et al.
VACCINE (2019)
Immune responses to zoster vaccines
Myron J. Levin et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
Immunogenicity of the Varicella-Zoster Vaccine in Community-Dwelling Non-robust Elderly Individuals Compared to Robust Elderly Individuals: A Prospective Cohort Study
Jung-Yeon Choi et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2019)
Cost-Effectiveness of Herpes Zoster Vaccination: A Systematic Review
Edward T. Chiyaka et al.
PHARMACOECONOMICS (2019)
Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines
Kathleen L. Dooling et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention
Nicolas Lecrenier et al.
EXPERT REVIEW OF VACCINES (2018)
Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older
Anthony L. Cunningham et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
Phuc Le et al.
JAMA INTERNAL MEDICINE (2018)
Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines
Pieter T. de Boer et al.
BMC MEDICINE (2018)
Recombinant Zoster Vaccine (Shingrix®): A Review in Herpes Zoster
Yahiya Y. Syed
DRUGS & AGING (2018)
Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis
Andrea C. Tricco et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Monitoring Interest in Herpes Zoster Vaccination: Analysis of Google Search Data
Elyse J. Berlinberg et al.
JMIR PUBLIC HEALTH AND SURVEILLANCE (2018)
Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older
Tino F. Schwarz et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Notes from the Field: Hospital Contact Investigation for a Patient Who Developed a Zoster Vaccine–Related Rash — Maryland, February 2015
Diana P. Le et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2017)
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
A. L. Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Vaccines against Herpes zoster: Effectiveness, safety, and cost/benefit ratio
Nabila Ferahta et al.
PRESSE MEDICALE (2016)
Recommendations for treatment and prevention of herpes zoster and associated pain in aged adults
P. -O. Lang et al.
REVUE DE MEDECINE INTERNE (2016)
Is herpes zoster an additional complication in old age alongside comorbidity and multiple medications? Results of the post hoc analysis of the 12-month longitudinal prospective observational ARIZONA cohort study
Gisèle Pickering et al.
BMJ Open (2016)
Cost-Effectiveness of Herpes Zoster Vaccine for Persons Aged 50 Years
Phuc Le et al.
ANNALS OF INTERNAL MEDICINE (2015)
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
Himal Lal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Cost-effectiveness analysis of a vaccination program for the prevention of herpes zoster and post-herpetic neuralgia in adults aged 50 and over in Germany
Emmanuelle Preaud et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Long-term Persistence of Zoster Vaccine Efficacy
Vicki A. Morrison et al.
CLINICAL INFECTIOUS DISEASES (2015)
A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients
Edward A. Stadtmauer et al.
BLOOD (2014)
Vaccination Against Zoster Remains Effective in Older Adults Who Later Undergo Chemotherapy
Hung Fu Tseng et al.
CLINICAL INFECTIOUS DISEASES (2014)
Herpes Zoster Caused by Vaccine-Strain Varicella Zoster Virus in an Immunocompetent Recipient of Zoster Vaccine
Hung Fu Tseng et al.
CLINICAL INFECTIOUS DISEASES (2014)
Vaccination in the Elderly: What Can Be Recommended?
Pierre-Olivier Lang et al.
DRUGS & AGING (2014)
Immunity and the Burden of Herpes Zoster
Won Suk Choi et al.
JOURNAL OF MEDICAL VIROLOGY (2014)
Concomitant Administration of Pneumococcal-23 and Zoster Vaccines Provides Adequate Herpes Zoster Coverage
Marcia J. Wyman et al.
ANNALS OF PHARMACOTHERAPY (2013)
Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany
Bernhard Ultsch et al.
BMC HEALTH SERVICES RESEARCH (2013)
Immune Senescence and Vaccination in the Elderly
Pierre Olivier Lang et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
Varicella-Zoster Virus-Specific Antibody Responses in 50-59-Year-Old Recipients of Zoster Vaccine
Myron J. Levin et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults ≥50 Years of Age
Roman Chlibek et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Herpes Zoster Eye Complications: Rates and Trends
Barbara P. Yawn et al.
MAYO CLINIC PROCEEDINGS (2013)
Early antiviral treatment fails to completely prevent herpes-related pain
C. Rabaud et al.
MEDECINE ET MALADIES INFECTIEUSES (2013)
Herpes Zoster
Jeffrey I. Cohen
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Cost-effectiveness of vaccination of the elderly against herpes zoster in The Netherlands
Pieter T. de Boer et al.
VACCINE (2013)
Vaccination against herpes zoster and postherpetic neuralgia in France: a cost-effectiveness analysis
Xavier Bresse et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2013)
Immunogenicity and safety of a live attenuated shingles (herpes zoster) vaccine (Zostavax®) in individuals aged ≥ 70 years
Timo Vesikari et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Persistence of the Efficacy of Zoster Vaccine in the Shingles Prevention Study and the Short-Term Persistence Substudy
K. E. Schmader et al.
CLINICAL INFECTIOUS DISEASES (2012)
Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50-59 Years
Kenneth E. Schmader et al.
CLINICAL INFECTIOUS DISEASES (2012)
A Phase 1/2 Clinical Trial Evaluating Safety and Immunogenicity of a Varicella Zoster Glycoprotein E Subunit Vaccine Candidate in Young and Older Adults
Isabel Leroux-Roels et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Patient perspective on herpes zoster and its complications: An observational prospective study in patients aged over 50 years in general practice
Didier Bouhassira et al.
PAIN (2012)
Association between central nervous system drugs and recurrent falling based on prospective falls registration in nursing homes
K. Szczerbinska et al.
EUROPEAN GERIATRIC MEDICINE (2012)
Acute Retinal Necrosis After Herpes Zoster Vaccination
Leon D. Charkoudian et al.
ARCHIVES OF OPHTHALMOLOGY (2011)
Economic evaluation of a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in older adults in Switzerland
Thomas D. Szucs et al.
HUMAN VACCINES (2011)
Promoting Life Course Vaccination
Jean-Pierre Michel et al.
REJUVENATION RESEARCH (2011)
Evaluation of the incidence of herpes zoster after concomitant administration of zoster vaccine and polysaccharide pneumococcal vaccine
Hung Fu Tseng et al.
VACCINE (2011)
The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study
Jie Zhang et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Safety of Herpes Zoster Vaccine in the Shingles Prevention Study A Randomized Trial
Michael S. Simberkoff et al.
ANNALS OF INTERNAL MEDICINE (2010)
Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands
Alies van Lier et al.
BMC HEALTH SERVICES RESEARCH (2010)
Safety and immunogenicity of a live attenuated varicella vaccine in VZV-seropositive HIV-infected adults
Adriana Weinberg et al.
HUMAN VACCINES (2010)
Concomitant administration of zoster and pneumococcal vaccines in adults ≥60 years old
C. Raina MacIntyre et al.
HUMAN VACCINES (2010)
Herpes zoster-related pain in aged individuals: How to manage it safely
P. -O. Lang et al.
EUROPEAN GERIATRIC MEDICINE (2010)
Health economic evaluation of a vaccine for the prevention of herpes zoster (shingles) and post-herpetic neuralgia in adults in Belgium
L. Annemans et al.
JOURNAL OF MEDICAL ECONOMICS (2010)
Infectious Encephalitis in France in 2007: A National Prospective Study
Alexandra Mailles et al.
CLINICAL INFECTIOUS DISEASES (2009)
Varicella-Zoster Virus-Specific Immune Responses to Herpes Zoster in Elderly Participants in a Trial of a Clinically Effective Zoster Vaccine
Adriana Weinberg et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Cost Effectiveness of Herpes Zoster Vaccine in Canada
Mehdi Najafzadeh et al.
PHARMACOECONOMICS (2009)
Herpes zoster in old adults
Pierre-Olivier Lang et al.
PRESSE MEDICALE (2009)
Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales
A. J. van Hoek et al.
VACCINE (2009)
Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older
Alicia N. Stein et al.
VACCINE (2009)
Willingness to vaccinate and to be vaccinated in adults
Jean-Pierre Baeyens et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2009)
The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia
Marc Brisson et al.
HUMAN VACCINES (2008)
Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine
M. J. Levin et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Vaccination against herpes zoster and postherpetic neuralgia
Michael N. Oxman et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Management of herpes zoster and postherpetic neuralgia
Stephen K. Tyring
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults
James M. Pellissier et al.
VACCINE (2007)
Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults
Michael B. Rothberg et al.
CLINICAL INFECTIOUS DISEASES (2007)
Post-herpetic neuralgia in older adults - Evidence-based approaches to clinical management
Paul J. Christo et al.
DRUGS & AGING (2007)
Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults
John Hornberger et al.
ANNALS OF INTERNAL MEDICINE (2006)
The burden of Herpes Zoster: A prospective population based study
FT Scott et al.
VACCINE (2006)
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults
MN Oxman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Characteristics of patients with herpes zoster on presentation to practitioners in France
C Chidiac et al.
CLINICAL INFECTIOUS DISEASES (2001)
The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales
WJ Edmunds et al.
VACCINE (2001)
分享论文
